Aprea Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APRE and other ETFs, options, and stocks.

About APRE

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. 

CEO
Oren Gilad
CEOOren Gilad
Employees
8
Employees8
Headquarters
Doylestown, Pennsylvania
HeadquartersDoylestown, Pennsylvania
Founded
2002
Founded2002
Employees
8
Employees8

APRE Key Statistics

Market cap
9.68M
Market cap9.68M
Price-Earnings ratio
-0.74
Price-Earnings ratio-0.74
Dividend yield
—
Dividend yield—
Average volume
35.61K
Average volume35.61K
High today
—
High today—
Low today
—
Low today—
Open price
$1.79
Open price$1.79
Volume
0.00
Volume0.00
52 Week high
$5.30
52 Week high$5.30
52 Week low
$1.41
52 Week low$1.41

People also own

Based on the portfolios of people who own APRE. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
NIO
AMC Entertainment
Lucid Group
Tilray Brands
Cenntro Inc.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.